BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PR, PGR, progesterone receptor
1150 results:

  • 1. The HLA-I landscape confers prognosis and antitumor immunity in breast cancer.
    Ding XH; Xiao Y; Chen F; Liu CL; Fu T; Shao ZM; Jiang YZ
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38602320
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer.
    Feng H; Zhang S; Zhou Q; Han F; Du G; Wang L; Yang X; Zhang X; Yu W; Wei F; Hao X; Ren X; Zhao H
    Front Immunol; 2024; 15():1302903. PubMed ID: 38500886
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
    Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
    Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
    Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
    Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
    Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
    Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
    Kikuchi K; Ogawa M; Sasaki A
    J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
    Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
    Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of phenomic profiles in the All of Us Research Program against the US general population and the UK Biobank.
    Zeng C; Schlueter DJ; Tran TC; Babbar A; Cassini T; Bastarache LA; Denny JC
    J Am Med Inform Assoc; 2024 Apr; 31(4):846-854. PubMed ID: 38263490
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The enigma of incisional hernia prediction unraveled: external validation of a prognostic model in colorectal cancer patients.
    Amro C; Smith L; Shulkin J; McGraw JR; Hill N; Broach RB; Torkington J; Fischer JP
    Hernia; 2024 Apr; 28(2):547-553. PubMed ID: 38227093
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
    Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
    EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Validity assessment of the POLARS score tool in the prediction of post rectal cancer surgery LARS score in a population-based Swedish cohort.
    Rethy B; Nordenvall C; Pieniowski E; Jansson-Palmer G; Johar A; Lagergren P; Abraham-Nordling M
    BMJ Open Gastroenterol; 2024 Jan; 11(1):. PubMed ID: 38199776
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
    Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
    Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics.
    Jiang P; Fan J; Huang S; Liu L; Bai M; Sun Q; Shen J; Zhang N; Liu D; Zhou N; Feng Y; Jiang J; Zhu J
    PeerJ; 2023; 11():e16631. PubMed ID: 38144182
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pneumorrhachis Secondary to a Locally Advanced Rectal cancer with Pre-Sacral Abscess-Case Report and Review.
    Diaconescu R; Popovici D; Tarta C; Isaic A; Costachescu D; Totolici B
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138179
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Application of the 'online assessment + FOBT at home' to improve participation and the efficacy of opportunistic screening for colorectal cancer: a retrospective cohort study.
    Peng X; Tang G; Wang Y; Zeng F; Chen Y; Zhang W; Mo C; Yang Y; Li S; Bai L; Xiao D; Zheng G; Ran W; Chen C; Yang Y; Gao Y; Zhu S; Huang Z; Zhao D; Wu C; Xu L; Wei Z
    BMC Public Health; 2023 Dec; 23(1):2534. PubMed ID: 38110887
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Compliance with Influenza Vaccination and Cervical, Breast, and colorectal cancer Screening in a Sample of Women in Puerto Rico: Community Engagement Efforts from PR-CEAL.
    Hill K; Pérez CM; Pons-Calvo A; Canales-Birriel K; López-Cepero A; Solís-Torres N; Tamarit-Quevedo Z; Colón-López V
    P R Health Sci J; 2023 Dec; 42(4):318-321. PubMed ID: 38104289
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
    Li M; Zheng W
    Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
    Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
    Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer.
    Di Donato M; Di Zazzo E; Salvati A; Sorrentino C; Giurato G; Fiore D; Proto MC; Rienzo M; Casamassimi A; Gazzerro P; Bifulco M; Castoria G; Weisz A; Nassa G; Abbondanza C
    J Transl Med; 2023 Oct; 21(1):736. PubMed ID: 37853459
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 58.